MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.breast.2026.104718

Медицинская библиотека · Breast (Edinburgh, Scotland) · 2026

Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.

de Mooij Cornelis M, Simons Janine M, van Amstel Florien J G, Mitea Cristina, van Diest Paul J, Nelemans Patty J, Mottaghy Felix M, van der Pol Carmen C, Luiten Ernest J T, Koppert Linetta B, Smidt Marjolein L, van Nijnatten Thiemo J A, REFINE Study Group

Контролируемое клиническое исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

In clinically node-positive patients, sentinel lymph node biopsy (SLNB), marking axillary lymph node with radioactive iodine seed (MARI), and combined SLNB/MARI (RISAS-procedure) can replace axillary lymph node dissection (ALND) after neoadjuvant systemic therapy. Surgical staging outcome can be combined with baseline axillary disease on 18F-FDG PET/CT. This study assessed whether baseline axillary disease on 18F-FDG PET/CT affects the accuracy of staging-procedures. Second, when staging-procedures detected residual disease, it was assessed whether baseline axillary disease on 18F-FDG PET/CT affected the probability of remaining positive nodes at completion ALND (cALND).

METHOD: Included were patients with baseline 18F-FDG PET/CT within the RISAStrial (NCT02800317). Patients underwent the RISAS-procedure followed by cALND. False negative rates were stratified by limited or advanced baseline axillary disease (1-3 vs. ≥4 hypermetabolic lymph nodes). When staging-procedures detected residual disease, the probability of remaining positive nodes at cALND was stratified by baseline axillary disease.

RESULTS

Of 185 patients, 116 had limited and 69 had advanced baseline axillary disease. Staging-procedures had higher accuracy in limited than advanced baseline axillary disease. When the RISAS-procedure detected residual disease, the probability of remaining positive nodes at cALND was lower in limited than advanced baseline axillary disease (44.9% vs. 91.5%,p < .001). When SLNB or MARI detected residual disease, the probability of remaining positive nodes at cALND was >88.4%, irrespective of baseline axillary disease.

CONCLUSION

Staging-procedures had higher accuracy in patients with limited than advanced axillary disease on baseline 18F-FDG PET/CT. When staging-procedures detected residual disease, the probability of remaining positive nodes at cALND remained high.

Для цитирования: de Mooij Cornelis M, Simons Janine M, van Amstel Florien J G, Mitea Cristina, van Diest Paul J, Nelemans Patty J, Mottaghy Felix M, van der Pol Carmen C, Luiten Ernest J T, Koppert Linetta B, Smidt Marjolein L, van Nijnatten Thiemo J A, REFINE Study Group. Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.. Breast (Edinburgh, Scotland). 2026. DOI: 10.1016/j.breast.2026.104718.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.